News
Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...
Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.
European drug company bosses say the answer to a perceived lack of competitiveness in the EU is to hike medicine prices to US ...
Below, we share with you three top-ranked healthcare mutual funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).
7h
Stockhead on MSNHealth Check: Snore-buster Resmed says miracle diet drugs and tariffs no threat to growthAfter reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will be a tailwind.
But Boeing faces industry supply-chain snags that have delayed some jet production even as planemakers’ backlogs swelled last ...
22h
Zacks Investment Research on MSNPfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy?Pfizer PFE will report its first-quarter earnings on April 29, before market open. The Zacks Consensus Estimate for sales and ...
Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss ...
22h
MarketBeat on MSNEli Lilly Nails Oral GLP-1 Trial-Here's What It Means for LLYCompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green ...
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...
QUAL's portfolio includes top tech and low beta stocks, offering diversification and stability. Read what makes QUAL ETF a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results